Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,516.37
(
-0.04%
)
US TECH 100
29,135.20
(
-0.26%
)
Dow Jones
50,670.15
(
0.41%
)
Brent Oil
92.96
(
-4.15%
)
Bitcoin
74,897.88
(
-1.25%
)
News Focus
News Focus
Post# of 257645
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123025
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 86526

Monday, 03/15/2010 7:36:03 PM

Monday, March 15, 2010 7:36:03 PM

Post# of 257645
LLY presents retrospective study of Plavix “poor metabolizers” from TRITON-TIMI study:

http://finance.yahoo.com/news/New-Analysis-Assesses-Impact-prnews-3233214455.html?x=0&.v=1

This line of attack is probably LLY’s best hope to improve on the feeble commercial uptake of Effient, which generated only $3.8M of worldwide in 4Q09 (#msg-46078363).


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now